Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer

Haa‐Na Song, Ki Sun Jung, Kwai Han Yoo, +11

Journal of Thoracic Oncology

MedicineAcquired C797s MutationCancer Cell BiologyPathologyCancer Genetics +4

Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience

Ahyoung Lim, Ji Hyeon Lee, Ki Sun Jung, +9

The Korean Journal of Internal Medicine

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer

Ji Yun Lee, Kyunghee Park, Sung Hee Lim, +17

Oncotarget

MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis

Ji Yun Lee, In-Kyoung Lee, Won Jin Chang, +17

Oncotarget

PathologyMct InhibitionMct4 ExpressionCancer BiologyTumor Biology +14

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, +9

Cancer Research and Treatment

A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib

Ji Yun Lee, Jong‐Mu Sun, Sung Hee Lim, +11

Clinical Cancer Research

Clinical features and treatment outcome of Epstein–Barr virus-positive nodal T-cell lymphoma

Ki Sun Jung, Su-Hee Cho, Seok Jin Kim, +2

International Journal of Hematology

Lymphoid NeoplasiaTreatment OutcomeImmunologyPathologyClinical Features +3

Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma

Ga‐Young Song, Dok Hyun Yoon, Cheolwon Suh, +10

Bone Marrow Transplantation

Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study

Eun Ju Park, Kwonoh Park, Jae‐Joon Kim, +7

Cancer Research and Treatment

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer

Ki Sun Jung, Jeeyun Lee, Se Hoon Park, +5

Molecular and Clinical Oncology

Mg SirolimusRefractory Cancer PatientsMedicinePathologyMolecular Oncology +10